PTPN2
PTPN2 (protein tyrosine phosphatase non-receptor type 2, also known as TC-PTP, TCPTP, TCELLPTP, TC45, TC48 and PTPT) is a non-receptor tyrosine-specific phosphatase. It dephosphorylates receptor and cytoplasmic kinases and STAT transcription factors, acting as a negative regulator of many signalling pathways. Browse Assay Genie's current range of PTPN2 research reagents below, or read on for the biology behind the target.
PTPN2 removes phosphate groups from tyrosine residues on its substrates. Among receptor protein tyrosine kinases, it dephosphorylates INSR, EGFR, CSF1R and PDGFR. It also acts on non-receptor kinases including JAK1, JAK2, JAK3 and Src family kinases, and on STAT1, STAT3 and STAT6, either in the nucleus or in the cytoplasm. Through these targets it negatively regulates processes such as haematopoiesis, the inflammatory response, cell proliferation and differentiation, and glucose homeostasis. It may also bind DNA.
In the immune system, PTPN2 has a multifaceted role in development. It contributes to T-cell receptor signalling by dephosphorylating FYN and LCK, thereby controlling T-cell differentiation and activation. It dephosphorylates CSF1R to limit downstream signalling and macrophage differentiation. It dampens IL-2 and interferon signalling through JAK1, JAK3 and STAT1, and regulates IL-6 and IL-4 signalling through STAT3 and STAT6. It also negatively regulates tumour necrosis factor-mediated signalling via MAPK through SRC dephosphorylation.
Outside the immune system, PTPN2 is involved in anchorage-dependent, negative regulation of EGF-stimulated cell growth. It is activated by the integrin ITGA1/ITGB1, dephosphorylates EGFR and PDGFRB, and may regulate signalling by the hepatocyte growth factor receptor MET. It restrains insulin receptor signalling through INSR and controls liver glucose production by limiting IL-6 signalling. The PTPN2 gene encodes a member of the protein-tyrosine phosphatase family, non-receptor class 1 subfamily, with a conserved catalytic motif essential for activity. Multiple alternatively spliced transcript variants encoding different isoforms have been reported, and the mouse and rat orthologs are both named Ptpn2.
PTPN2 dephosphorylates JAK1, JAK2, JAK3, STAT1, STAT3 and STAT6, making it a key node for studying cytokine signalling control.
By dephosphorylating FYN and LCK, PTPN2 controls T-cell differentiation and activation and contributes to immune system development.
PTPN2 dephosphorylates EGFR, PDGFRB, CSF1R and MET, limiting growth factor signalling and cell proliferation.
PTPN2 negatively regulates insulin receptor signalling and IL-6-dependent hepatic gluconeogenesis, linking phosphatase activity to glucose control.
PTPN2 is a tyrosine-specific phosphatase that dephosphorylates receptor kinases such as INSR, EGFR, CSF1R and PDGFR, plus JAK family kinases, Src family kinases and STAT proteins. In doing so it negatively regulates cytokine, growth factor and insulin signalling, and contributes to T-cell regulation.
PTPN2 is also called TC-PTP, TCPTP, TCELLPTP, TC45, TC48 and PTPT. The full name is protein tyrosine phosphatase non-receptor type 2. UniProt lists it as tyrosine-protein phosphatase non-receptor type 2, and multiple alternatively spliced transcript variants encoding different isoforms have been described.
Orthologs of the PTPN2 gene exist in mouse and rat, where the symbol is also Ptpn2. Two highly related but distinctly processed pseudogenes have been reported on human chromosomes 1 and 13. Check the datasheet of any product for its validated reactivity.
Other non-receptor protein tyrosine phosphatases that regulate kinase and cytokine signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P17706; product specifications from Assay Genie datasheets.